A gender clinic is being forced to shut down after a review found it was reckless in prescribing puberty blockers to vulnerable teenagers.

Reviewer Dr. Hilary Cass, appointed by The National Health Service (NHS) of the UK, released her findings after conducting an extensive review.

“A fundamentally different service model is needed which is more in line with other paediatric provisions, to provide timely and appropriate care for children and young people needing support around their gender identity,” read Cass’s review submitted in March.

Cass’s review included data from 9,000 individuals who had attended the clinic as patients.

She further stated that vulnerable children, who often suffer from clinical issues beyond gender dysphoria, need to be assessed by the appropriate health authorities with a more holistic approach.

In light of Cass’s report, the NHS has shut down the Tavistock Gender Clinic, England’s only specialized clinic that treated children and teenagers for gender dysphoria.

The NHS and the Tavistock Gender Clinic were also sued in 2018 – and lost in 2020 – after Kiera Bell sued both parties for not protecting young patients while conducting “experimental treatment with life-altering outcomes.”

Bell describes her sex transition – and subsequent de-transition – in her Substack.

“The further my transition went, the more I realized that I wasn’t a man and never would be. We are told these days that when someone presents with gender dysphoria, this reflects a person’s “real” or “true” self, that the desire to change genders is set. But this was not the case for me. As I matured, I recognized that gender dysphoria was a symptom of my overall misery, not its cause.”

The number of patients being referred to Tavistock had grown exponentially over the past ten years, a phenomenon that seems to be occurring throughout much of the gender-obsessed west.

Nonetheless, it’s hard to deny that drugs given to kids with gender dysphoria are anything but experimental, given the lack of long-term data.

To this point, the FDA just warned that puberty blockers could cause brain swelling and vision loss. 

Indeed, it’s no surprise that more lawsuits are coming the NHS’s way – and likely, more will surface towards similar institutions that conduct such ‘treatments’ for youth. In fact, in Canada, the transgender uptick is so rampant that clinics are advising doctors to start hormone therapy before they even visit the specialists for the first time.

And if the growing number of horror stories aren’t enough to effect policy change, perhaps more lawsuits will.